News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78,791 Results
Type
Article (9439)
Company Profile (52)
Press Release (69300)
Multimedia
Podcasts (3)
Webinars (2)
Section
Business (21666)
Career Advice (105)
Deals (3049)
Drug Delivery (9)
Drug Development (12100)
Employer Resources (14)
FDA (1709)
Job Trends (2208)
News (37510)
Policy (3141)
Tag
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2026 Genetown Elite (1)
Academia (644)
Accelerated approval (1)
Adcomms (5)
Allergies (3)
Alliances (6898)
ALS (20)
Alzheimer's disease (259)
Antibody-drug conjugate (ADC) (6)
Approvals (1707)
Artificial intelligence (40)
Autoimmune disease (1)
Automation (2)
Bankruptcy (14)
Best Places to Work (2106)
BIOSECURE Act (2)
Biosimilars (6)
Biotechnology (47)
Bladder cancer (8)
Brain cancer (8)
Breast cancer (33)
Cancer (287)
Cardiovascular disease (32)
Career advice (92)
Career pathing (1)
CAR-T (32)
Cell therapy (101)
Clinical research (9185)
Collaboration (172)
Compensation (66)
Complete response letters (4)
COVID-19 (370)
CRISPR (24)
C-suite (30)
Cystic fibrosis (58)
Data (411)
Depression (2)
Diabetes (26)
Diagnostics (1481)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (28)
Drug pricing (4)
Duchenne muscular dystrophy (44)
Earnings (6616)
Editorial (5)
Employer branding (3)
Employer resources (13)
Events (11652)
Executive appointments (75)
FDA (1886)
Featured Employer (12)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (107)
Gene editing (65)
Generative AI (2)
Gene therapy (151)
GLP-1 (68)
Government (479)
Grass and pollen (1)
Guidances (6)
Healthcare (2281)
Huntington's disease (7)
IgA nephropathy (2)
Immunology and inflammation (9)
Indications (5)
Infectious disease (389)
Inflammatory bowel disease (22)
Inflation Reduction Act (1)
Influenza (4)
Intellectual property (10)
Interviews (14)
IPO (1562)
IRA (1)
Job creations (263)
Job search strategy (89)
Kidney cancer (1)
Labor market (2)
Layoffs (52)
Legal (390)
Liver cancer (7)
Lung cancer (31)
Lymphoma (28)
Management (1)
Manufacturing (33)
MASH (2)
Medical device (299)
Medtech (299)
Mergers & acquisitions (1556)
Metabolic disorders (81)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (22)
Neuropsychiatric disorders (2)
Neuroscience (366)
NextGen: Class of 2025 (733)
Non-profit (658)
Northern California (435)
Now hiring (4)
Obesity (51)
Opinion (36)
Ovarian cancer (1)
Pain (9)
Pancreatic cancer (11)
Parkinson's disease (34)
Partnered (2)
Patents (19)
Patient recruitment (10)
People (7011)
Pharmaceutical (3)
Phase I (3530)
Phase II (4218)
Phase III (2943)
Pipeline (174)
Policy (7)
Postmarket research (212)
Preclinical (1577)
Press Release (18)
Prostate cancer (5)
Psychedelics (3)
Radiopharmaceuticals (16)
Rare diseases (179)
Real estate (491)
Recruiting (3)
Regulatory (2585)
Reports (8)
Research institute (767)
Resumes & cover letters (11)
Rett syndrome (4)
RNA editing (3)
RSV (1)
Schizophrenia (5)
Series A (24)
Series B (13)
Service/supplier (1)
Sickle cell disease (20)
Southern California (299)
Special edition (2)
Spinal muscular atrophy (132)
Sponsored (5)
Startups (611)
Supply chain (2)
Tariffs (1)
The Weekly (3)
United States (3298)
Vaccines (71)
Venture capitalists (4)
Weight loss (10)
Women's health (2)
Date
Last 7 days (77)
Last 30 days (341)
Last 365 days (5224)
2025 (1356)
2024 (5465)
2023 (5859)
2022 (7883)
2021 (8238)
2020 (6721)
2019 (5474)
2018 (4089)
2017 (4206)
2016 (3769)
2015 (4323)
2014 (3033)
2013 (2417)
2012 (2186)
2011 (2175)
2010 (1917)
Location
Africa (91)
Alabama (3)
Alaska (2)
Arizona (14)
Arkansas (1)
Asia (3739)
Australia (758)
California (897)
Canada (177)
China (47)
Colorado (32)
Connecticut (39)
Delaware (7)
Europe (10404)
Florida (92)
Georgia (6)
Idaho (4)
Illinois (26)
India (2)
Indiana (77)
Iowa (1)
Japan (34)
Kansas (5)
Kentucky (4)
Louisiana (2)
Maine (2)
Maryland (106)
Massachusetts (913)
Michigan (45)
Minnesota (9)
Missouri (3)
Montana (2)
Nebraska (4)
Nevada (8)
New Hampshire (3)
New Jersey (170)
New Mexico (3)
New York (228)
North Carolina (149)
North Dakota (4)
Northern California (435)
Ohio (31)
Oklahoma (1)
Oregon (4)
Pennsylvania (197)
Rhode Island (4)
South America (116)
South Carolina (1)
Southern California (299)
Tennessee (1)
Texas (112)
Utah (66)
Virginia (29)
Washington D.C. (7)
Washington State (96)
Wisconsin (6)
78,791 Results for "veritas genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024
Veritas will have a prominent presence at the upcoming European Society of Human Genetics Congress 2024, to be held in Berlin from June 1 to 4.
May 29, 2024
·
3 min read
Press Releases
Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients
October 3, 2024
·
2 min read
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting
March 11, 2025
·
3 min read
Press Releases
Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
March 21, 2025
·
3 min read
Business
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita
Tevogen Bio Holdings, congratulates Victor Sordillo PE, CSP, MBA, on his recent appointment as Managing Director of Risk Advisory Services at Verita CSG, Inc., a provider of holistic insurance and risk management solutions for commercial line clients.
March 5, 2024
·
6 min read
Press Releases
Opus Genetics to Participate in Upcoming Investor Conference in April
April 2, 2025
·
6 min read
Press Releases
Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
January 23, 2025
·
4 min read
Press Releases
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
April 8, 2025
·
3 min read
Press Releases
Opus Genetics Announces Financial Results for Full Year 2024
April 1, 2025
·
20 min read
1 of 7,880
Next
